英文名称 | 中文名称 | CAS | MF |
1,4-PIPERAZINE BIS (PROPANESULFONIC ACID)
|
|
|
C10H22N2O6S2
|
3,4-Piperidinediol, 4-methyl-1-(phenylmethyl)- (9CI)
|
|
441012-33-5
|
C13H19NO2
|
Piperazine, 1-(3-hydroxy-1-oxopropyl)-4-methyl- (9CI)
|
|
118779-37-6
|
C8H16N2O2
|
Piperazine, 1-methyl-2-[2-(methylthio)ethyl]-, (2S)- (9CI)
|
|
660862-42-0
|
C8H18N2S
|
Piperazine, 1-methyl-4-(2-thienyl)- (9CI)
|
|
151657-62-4
|
C9H14N2S
|
3-Piperidinol, 2,2,5-trimethyl- (9CI)
|
|
381680-27-9
|
C8H17NO
|
2,6-Piperidinedione, 3-ethyl-
|
|
25115-69-9
|
|
Piperidine, 4-methyl-1-(2-piperidinylcarbonyl)- (9CI)
|
|
782449-57-4
|
C12H22N2O
|
3-Piperidinecarboxylic acid, 1-formyl- (9CI)
|
|
496057-38-6
|
C7H11NO3
|
Piperazine, 1-(2-methoxyphenyl)-4-[(1,2,4-triazolo[4,3-a]pyrimidin-3-ylthio)acetyl]- (9CI)
|
|
606121-75-9
|
C18H20N6O2S
|
2,3-Piperazinedione, 1-(chloroacetyl)-4-ethyl- (9CI)
|
|
199387-10-5
|
C8H11ClN2O3
|
4-(1-PIPERIDINYL)-1-BUTANOL
|
|
|
C9H19NO
|
4-(PIPERIDIN-4-YLAMINO)-BENZOIC ACID ETHYL ESTER
|
4-(4-哌啶基氨基)苯甲酸乙酯
|
886362-80-7
|
C14H20N2O2
|
4-[(2-Piperidin-1-ylethyl)carbamoyl]benzeneboronic acid hydrochloride 98%
|
|
|
C14H21BN2O3.ClH
|
4-(3-piperidin-1-ylpropoxy)benzoic acid Hydrochloride
|
|
685565-09-7
|
|
Piperidine, 5-(3-methoxyphenyl)-2,5-dimethyl-, cis- (9CI)
|
|
791744-05-3
|
C14H21NO
|
Piperazine, 1,4-bis[(1,1-dimethylethyl)thio]-
|
|
56771-87-0
|
|
PIPERAZLINE FERULATE
|
|
|
|
1-Piperazinepropanamide, N-(4-(aminosulfonyl)phenyl)-4-(2-pyridinyl)-
|
|
86523-78-6
|
|
1-Piperazinepropanamide, N-(3-(dimethylamino)phenyl)-4-(diphenylmethyl )-, hydrochloride, hydrate (2:6:1)
|
|
107314-65-8
|
C28H34N4O.3ClH.H2O
|
4-(PIPERIDINO)PHENYLBORONIC ACID
|
|
|
C11H16BNO2
|
1-Piperazinepropanamide, N-(4-(1-hydroxyethyl)phenyl)-4-(2-pyridinyl)-
|
|
86523-83-3
|
|
Piperidinium, 1-ethyl-1-methyl-, iodide
|
|
4186-71-4
|
|
3-PIPERIDINOPROPYLP-CHLOROBENZOATEHYDROCHLORIDE
|
|
|
|
3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R,3S,4R,5R)- (9CI)
|
|
757235-48-6
|
C10H21NO4
|
Piperazine, polymer with (chloromethyl)oxirane, compd. with (chloromethyl)benzene
|
|
110438-26-1
|
|
4-Piperidinol, 1-(methoxymethyl)- (9CI)
|
|
704869-74-9
|
C7H15NO2
|
3,4,5-Piperidinetriol, 2-(1H-1,2,4-triazol-1-ylmethyl)-, (2R,3R,4R,5S)- (9CI)
|
|
748814-86-0
|
C8H14N4O3
|
2,5-Piperazinedione, 3-[(1R)-1-hydroxyethyl]-, (3S)- (9CI)
|
|
67106-24-5
|
C6H10N2O3
|
4-Piperidinecarboxaldehyde, 1-(trifluoroacetyl)- (9CI)
|
|
401948-16-1
|
C8H10F3NO2
|
1-Piperazineethanol, 4-(diphenylmethyl)-alpha-(4-hydroxyphenyl)-, mono hydrochloride
|
|
87429-91-2
|
|
Piperidine, 1-ethyl-3-(3-ethyl-2-pyrrolidinyl)- (9CI)
|
|
525537-99-9
|
C13H26N2
|
3,4-Piperidinediol, 1-ethyl-, (3R,4R)-rel- (9CI)
|
|
660403-83-8
|
C7H15NO2
|
3,4-Piperidinediol, 5-(hydroxymethyl)-, (3R,4R,5S)-rel- (9CI)
|
|
275363-93-4
|
C6H13NO3
|
Piperazine, 1-methyl-4-(1-oxopropyl)- (9CI)
|
|
63867-55-0
|
C8H16N2O
|
4-Piperidin-1-yl-butyric acid ethyl ester
|
|
116885-98-4
|
|
1-Piperazinepropanamide, N-(2-aminophenyl)-4-(2-pyridinyl)-
|
|
86523-91-3
|
|
Piperazine, 1-(beta-(sec-butyl)-5-chloro-2-ethoxyphenethyl)-4-methyl-
|
|
29122-64-3
|
|
2-Piperidineethanol, 1-acetyl-, (R)- (9CI)
|
|
111479-25-5
|
C9H17NO2
|
Piperazinone, 3-(2-(4-bromophenyl)-2-oxoethylidene)-
|
|
63656-19-9
|
|
Piperazine, 2,5-dimethyl-1-propyl-, (2R-trans)- (9CI)
|
|
192520-99-3
|
C9H20N2
|
Piperazine, 1,4-dihydroxy-2,2,5,6-tetramethyl- (9CI)
|
|
88571-72-6
|
C8H18N2O2
|
Piperidinium, 3-[(hydroxydiphenylacetyl)oxy]-1,1-dimethyl-, bromide, (R)-
|
|
92842-81-4
|
|
4-Piperidinamine, 1-acetyl-N,N-dimethyl- (9CI)
|
|
497838-40-1
|
C9H19N2O
|
Piperidine, 3-methyl-1-[(4-methylphenyl)acetyl]- (9CI)
|
|
599161-75-8
|
C15H21NO
|
Piperazine, 1-(1,1-dimethylethyl)-4-nitroso- (9CI)
|
|
107938-04-5
|
C8H17N3O
|
Piperazinone, 3-(1-cyclopenten-1-yl)- (9CI)
|
|
476364-38-2
|
C9H14N2O
|
Piperazinium, 4-carboxy-1-(2-heptynyl)-1-methyl-, bromide, ethyl ester
|
|
109699-57-2
|
|
5-Piperidinovaleronitrile
|
|
4734-49-0
|
C10H18N2
|
4-[2-(1-piperidine) ethoxy]benzoic acid Hcl (intermediate of raloxifene)
|
|
|
|
1-PIPERAZINEACETAMIDE, N-(4-FLUOROPHENYL)-4-(PHENYLMETHYL)
|
|
256943-68-7
|
C19H22FN3O
|
4-piperidin-4-yl-5-(trifluoromethyl)pyrimidine
|
|
|
C10H12F3N3
|
3-piperidin-3-yl[1,2,4]triazolo[4,3-a]pyrazine
|
|
|
C10H13N5
|
2,4-Piperidinedione, 3-acetyl-6-methyl- (9CI)
|
|
127952-78-7
|
C8H11NO3
|
2-Piperidinemethanamine, 1-acetyl-, (S)- (9CI)
|
|
138344-69-1
|
C8H16N2O
|
3,4-Piperidinediol, 1-acetyl- (7CI)
|
|
89895-83-0
|
C7H13NO3
|
Piperazine, 1-hydroxy-4-phenyl- (9CI)
|
|
87725-43-7
|
C10H14N2O
|
Piperazine, 1-acetyl-4-[3-(4-methoxyphenyl)isothiazolo[4,5-d]pyrimidin-7-yl]- (9CI)
|
|
604741-44-8
|
C18H19N5O2S
|
2-Piperidineacetic acid, 3,4,5-trihydroxy-, ethyl ester, [2R-(2alpha,3alpha,4alpha,5alpha)]- (9CI)
|
|
753429-43-5
|
C9H17NO5
|
3-Piperidinecarboxamide, 1-(4,6-dimethyl-2-pyrimidinyl)-N-[1-(4-methoxyphenyl)ethyl]- (9CI)
|
|
606106-72-3
|
C21H28N4O2
|
2-Piperidinone, 3,4-dihydroxy-5-methyl-, (3R,4R,5R)- (9CI)
|
|
536744-86-2
|
C6H11NO3
|
Piperazine, 1,4-di-2-propenyl- (9CI)
|
|
13173-24-5
|
C10H18N2
|
Piperazine, 1-[(2S)-2-amino-4-methyl-1-oxopentyl]-4-ethyl- (9CI)
|
|
720656-32-6
|
C12H25N3O
|
Piperazinone, 1-(2-methylphenyl)- (9CI)
|
|
150705-53-6
|
C11H14N2O
|
Piperazine, 2-methyl-1-(1-oxopropyl)- (9CI)
|
|
314729-13-0
|
C8H16N2O
|
Piperazine, 2-[2-(3-furanyl)ethyl]-, (2S)- (9CI)
|
|
612504-90-2
|
C10H16N2O
|
4-Piperidinol, 1-(chlorodifluoroacetyl)- (9CI)
|
|
478258-79-6
|
C7H10ClF2NO2
|
2-Piperidinecarboxylic acid, 5-hydroxy-, methyl ester, (2S,5S)- (9CI)
|
(2S,5S)-5-羟基-2-哌啶羧酸甲酯
|
695183-75-6
|
C7H13NO3
|
Piperazine, 2-methyl-1-(phenylmethyl)-, (2R)- (9CI)
|
(R)-1-苄基2甲基哌嗪
|
174671-42-2
|
C12H18N2
|
Piperazine, 1-[(ethylthio)methyl]-4-methyl- (6CI)
|
|
99114-77-9
|
C8 H18 N2 S
|
Piperazine, 1-(1H-benzimidazol-4-yl)-4-((5-(methylthio)-1,3,4-oxadiazo l-2-yl)carbonyl)-
|
|
84806-81-5
|
|
3-[[2-(piperazin-1-yl)ethyl]amino]propiononitrile
|
|
68310-66-7
|
C9H18N4
|
1-Piperidinecarboximidamide, 4-hydroxy-N-methyl- (9CI)
|
|
684207-49-6
|
C7H15N3O
|
2-Piperidinethione, 1-acetyl- (9CI)
|
|
121003-23-4
|
C7H11NOS
|
11-(1-Piperazinyl-d8)-dibenzo[b,f][1,4]thiazepin-7-ol
|
|
1246819-53-3
|
C17H9D8N3OS
|
3-piperidin-4-yl[1,2,4]triazolo[4,3-a]pyrazine
|
|
|
C10H13N5
|
2,4-Piperidinedione, 3-(1-hydroxyethylidene)- (9CI)
|
|
226704-37-6
|
C7H9NO3
|
2-Piperidinone, 1-acetyl-6-fluoro- (9CI)
|
|
246181-67-9
|
C7H10FNO2
|
Piperazine, 1-(1H-imidazol-4-ylmethyl)-4-methyl- (9CI)
|
|
279679-93-5
|
C9H16N4
|
Piperazine, 1-ethyl-4-(1-methyl-4-piperidinyl)- (9CI)
|
|
416867-23-7
|
C12H25N3
|
piperidinium laurate
|
|
28692-94-6
|
C17H35NO2
|
2-Piperidinone, 1-ethyl-4-hydroxy-3-methyl-, (3R,4R)-rel- (9CI)
|
|
343138-40-9
|
C8H15NO2
|
2,5-Piperazinedione, 1-acetyl-3-methylene- (9CI)
|
|
219608-32-9
|
C7H8N2O3
|
2-Piperidino-ethylazide
|
|
138373-73-6
|
C7H14N4
|
1-Piperidinecarboxaldehyde, 2-propyl- (9CI)
|
|
134253-35-3
|
C9H17NO
|
1-Piperidinepropanol, α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-, [1α,2α(R*),4α]-
|
|
163296-11-5
|
|
2-piperazin-1-ylpyrazine
|
|
|
C8H12N4
|
Piperidine, 3-ethylidene-1-(1-methylethyl)-, (E)- (9CI)
|
|
204975-59-7
|
C10H19N
|
Piperazine, 2-[(3-methylphenyl)methyl]-, (2S)- (9CI)
|
|
612502-35-9
|
C12H18N2
|
Piperazine, 1-acetyl-2-ethenyl- (9CI)
|
|
176851-74-4
|
C8H14N2O
|
4-(1-PIPERIDINYLSULFONYL)ANILINE
|
|
|
C11H16N2O2S
|
2-(PIPERIDIN-4-YLSULPHANYL)PYRIDINE DIHYDROCHLORIDE
|
|
|
C10H16Cl2N2S
|
Piperidine, 4-methyl-1-[(tetrahydro-2-furanyl)carbonyl]- (9CI)
|
|
560090-38-2
|
C11H19NO2
|
Piperidine, 2-methyl-1-[(4-methylphenyl)acetyl]- (9CI)
|
|
599162-30-8
|
C15H21NO
|
2-Piperazinemethanamine, 1-acetyl- (9CI)
|
|
147557-08-2
|
C7H15N3O
|
4-Piperidinone, 1-acetyl-2,6-dimethyl-, (2R,6R)-rel- (9CI)
|
|
625086-90-0
|
C9H15NO2
|
Piperazine, 2-[2-(4-pyridinyl)ethyl]-, (2S)- (9CI)
|
|
612503-14-7
|
C11H17N3
|
Piperazine, 1-(4-chlorobenzoyl)-4-[4-(4-methylphenyl)-2-thiazolyl]- (9CI)
|
|
606087-71-2
|
C21H20ClN3OS
|
Piperazine, 1-(1-oxo-2-propenyl)-4-propyl- (9CI)
|
|
308087-17-4
|
C10H18N2O
|
Piperidine, 1-[(aminooxy)acetyl]- (9CI)
|
|
741246-54-8
|
C7H14N2O2
|